Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments (PCS-HBOT)
Post COVID-19 Condition, Post-COVID-19 Syndrome, Post-COVID Syndrome
About this trial
This is an interventional treatment trial for Post COVID-19 Condition focused on measuring Hyperbaric Oxygen Therapy, HBOT, Post COVID-19 Condition, Fatigue, SARS-CoV-2, COVID-19
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years old Officially diagnosed with post COVID-19 condition by a healthcare practitioner At least three months since SARS-CoV-2 infection Symptoms that persist more than 12 weeks: Chronic fatigue (must include) along with one of the following symptoms: Difficulty thinking or problem solving ('brain fog') Stress or anxiety Known pregnancy or planning a pregnancy in women of childbearing age Exclusion Criteria: 1) Contraindications/medically unfit to receive hyperbaric treatments at an outpatient facility (pneumothorax, in-patients, requiring infusions to maintain hemodynamics, active and unstable coronary disease) 2) Patients with cognitive difficulties and/or mental retardation before COVID diagnosis 3) History of traumatic brain injury 4) Unlikely to comply with follow-up assessments (e.g. no fixed address, plans to move out of town) -
Sites / Locations
- Sunnybrook Health Sciences Centre
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Immediate start of hyperbaric treatments
Delayed start of hyperbaric treatments
HBOT treatments will be scheduled to start immediately after referral.
HBOT treatments will be scheduled to start 90 days after referral.